Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Health Economics and Outcomes Research|February 5, 2024
Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host DiseaseAdrian Peacock, Frances C Dehle, Oscar A Mesa Zapata, et al.
European Journal of Clinical Pharmacology|September 19, 2024
The impact of age and renal function on the pharmacokinetics and protein binding characteristics of fludarabine in paediatric and adult patients undergoing allogeneic haematopoietic stem cell transplantation conditioningChrista E Nath, Sebastian P A Rosser, Kiran K Nath, et al.
Journal of Psychosocial Oncology|January 20, 2021
Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivorsLisa Brice, Nicole Gilroy, Gemma Dyer, et al.
European Journal of Clinical Pharmacology|October 7, 2022
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myelomaChrista Ellen Nath, Andrew Grigg, Sebastian P A Rosser, et al.
Frontiers in Oncology|September 4, 2025
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimizationPhoebe Joy Ho, Vinay Vanguru, Cale S Burge, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 5, 2016
Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?Lisa Brice, Nicole Gilroy, Gemma Dyer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2016
Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW AustraliaJennifer Smith, Christine Poon, Nicole Gilroy, et al.
Bone Marrow Transplantation|April 20, 2022
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRRDavid Kliman, Steven Tran, Glen Kennedy, et al.
Blood Advances|September 4, 2020
Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemicDuncan Purtill, Vicki Antonenas, Paul Chiappini, et al.
Transplantation and Cellular Therapy|January 8, 2025
Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More TherapiesEdward Abadir, Rebecca Wayte, Wenlong Li, et al.
Pageof 4